Caterina Oneto Araya, MD
Gastroenterology · New York, NYNPI 1245559764
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $461,251 of the $610,152 with a category attached, or 75.6%. 33 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 43.6% of the total. Reporting peaked in 2023 at $169,058 and has fallen 89.0% since, to $18,641 in 2025. Among gastroenterology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,416 payments — averaging $430.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$266K
- AbbVie$120K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$89K
- Ferring Pharmaceuticals Inc.$57K
- Phathom Pharmaceuticals, Inc.$43K
- Pfizer$15K
- plus $20K from 27 others
Across 45 payments — averaging $4475.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$140K
- E.r. Squibb & Sons, L.L.C.$31K
- Bausch Health US, LLC$16K
- Roche Products Limited$10K
- Ferring Pharmaceuticals AS$5K
What the payments were for
- Consulting fees$59,00010%
- Speaking & faculty fees$461,25176%
- Travel & lodging$52,8549%
- Food & beverage$35,8736%
- Education$1,1750%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 179 | $265,999 |
| AbbVie(2 entities) | 323 | $120,047 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 319 | $89,297 |
| Ferring Pharmaceuticals Inc. | 80 | $57,093 |
| Phathom Pharmaceuticals, Inc. | 63 | $43,135 |
| Pfizer | 83 | $14,502 |
| Bristol Myers Squibb | 90 | $6,246 |
| Romark Laboratories, LC | 10 | $4,917 |
| Aimmune Therapeutics, Inc. | 2 | $1,638 |
| Takeda Pharmaceuticals U.S.A., Inc. | 85 | $1,497 |
| Sanofi | 6 | $1,494 |
| QOL Medical, LLC | 51 | $1,427 |
| Merck | 23 | $491 |
| Johnson & Johnson | 23 | $479 |
| Redhill Biopharma Inc. | 22 | $476 |
| Regeneron Healthcare Solutions, Inc. | 9 | $307 |
| Ardelyx, Inc. | 4 | $163 |
| Lilly USA, LLC | 7 | $153 |
| Ironwood Pharmaceuticals, Inc | 7 | $141 |
| Braintree Laboratories, Inc. | 5 | $105 |
| Blueprint Medicines Corporation | 3 | $94 |
| Vivus LLC | 4 | $79 |
| Nestle Healthcare Nutrition Inc. | 4 | $79 |
| Daiichi Sankyo Inc. | 3 | $67 |
| Gilead | 2 | $47 |
| Intercept Pharmaceuticals, Inc. | 2 | $39 |
| Organon | 1 | $25 |
| EMD Serono, Inc. | 1 | $24 |
| Capsovision, Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| UCB, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$610,152 in reported general payments places this provider in the 95th percentile of 1,682 gastroenterology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 26 | $9,672 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 13 | $880 |
| Omeprazole | 58 | $480 |
| Pantoprazole Sodium | 21 | $234 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in New York
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
- Sonal KumarNew York$1M
- David PoppersNew York$939K
- Ellen ScherlNew York$857K
- Bruce SandsNew York$810K
- Jean Frederick ColombelNew York$786K
- Seth GrossNew York$624K
- Dana LukinNew York$491K
- Ilan WeisbergNew York$446K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.